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Abstract
BACKGROUND: Brainstem evoked response audiometry (BERA) is not widely used for hearing screening because 
it is considered less practical; however, it is often used for diagnostics. Since the founding of automated auditory 
brainstem response (AABR), it often uses because it is more practical, has a high sensitivity and specificity in early 
detection of hearing loss (HL) in high-risk infants.
AIM: The objective of the study was to determine the differences results of AABR and BERA for HL detection in high-
risk infants at neonatal intensive care unit (NICU).
METHODS: The study was conducted from November 2014 to September 2015 with consecutive sampling. The 
subjects were high-risk infants treated in the NICU room of the Neonatology Division at Dr. Soetomo General 
Hospital Surabaya and examined using AABR or BERA to determine the existence of HL.
RESULTS: BERA results obtained normal (negative) as many as 28 ears (73.68%) and not normal (positive) as 
many as 10 ears (26.32%). AABR results obtained pass (negative) as many as 23 ears (60.53%) and refer (positive) 
as many as 15 ears (39.47%). Detection of HL in high-risk infants in NICU with AABR obtained 40% of sensitivity and 
60.71% of specificity, 26.67% of positive prediction (NPP), 73.91% of negative predictive value (NPN), 55.26% of 
accuracy, 39.29% of false positive error rate, and 60% of false negative error rate. The comparative test of Wilcoxon 
signed-rank between the results of AABR and BER obtained p = 0.236.
CONCLUSIONS: There was no difference between AABR and BERA results for HL detection in high-risk infants at 
NICU.
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Introduction
Early detection of hearing loss (HL) in newborns 
and infants by newborn hearing screening is necessary 
for early treatment [1]. The best method to assess 
the threshold of a hearing was the brainstem evoked 
response audiometry (BERA). BERA is not widely used 
for hearing screening because it is considered less 
practical; however, it is often used for diagnostics. Since 
the founding of a second-generation BERA tool called 
automated auditory brainstem response (AABR), this 
tool is often used for hearing screening programs [2].
AABR is automatic BERA which can be done 
quickly and does not require analysis of evoked potential 
waves. The results are very easy to read because it 
is only based on pass or refer criteria. Several studies 
have shown that AABR has been widely used for 
hearing screening due to its advantages that are more 
practical, have high sensitivity and specificity in early 
detection of HL in high-risk infants. In Germany, AABR 
has a sensitivity of 98% and a specificity of 96%. In Italy 
reported, 378 (97.4%) of 388 ears examined showed 
an agreement using two techniques of AABR and 
BERA, whereas 10 ears (2.6%) showed no agreement 
using two techniques of AABR and BERA. The result 
of an interobserver agreement between AABR and 
BERA results was very good (kappa = 0.92 ± 0.02 S.E., 
p = 0.0001) and it had 100% of sensitivity and 96.8% of 
specificity [3].
High-risk infants underwent treatment at 
neonatal intensive care unit (NICU) were at high risk of 
HL. Abnormalities can cause HL in newborns, that is, 
asphyxia, sepsis, hyperbilirubinemia, low birth weight 
(LBW), and premature [4], [5], [6], [7]. High-risk infants 
who have hypoxia and ischemia in the tissues resulting 
in apoptosis that causes irreversible damage to the 
cochlea and damage to auditory nerve fibers, thus the 
auditory signal cannot be passed to the brainstem [8].
Sepsis in high-risk infants will be accompanied 
by systemic toxemia. The infection gets into the 
bloodstream, stria vascularis, endolymph, and perilymph; 
then it causes hemagglutination and hypercoagulation. 
Cochlear blood flow decreases that damage the cochlea 
and central nervous system resulting in HL [9]. High-risk 
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infants with LBW and premature birth often experience 
neurodevelopmental complications and congenital 
abnormalities. Serum bilirubin levels of >17 mg/dL in 
infant blood cause in damage to the cochlea, and auditory 
nerve fibers due to bilirubin toxin, thus the auditory 
signal to the brainstem is disrupted [10]. Research on 
the comparison between AABR and BERA has rarely 
reported abroad. Thus, we aimed to obtain the difference 
of AABR and BERA for HL detection in high-risk infants 
at NICU of Dr. Soetomo General Hospital Surabaya.
Methods
This was an observational analytic study that 
used a cross-sectional approach. The sampling used 
was consecutive sampling until the minimum size 
fulfilled. Inclusion criteria were high-risk infants aged 
0–3 months who suffer from asphyxia, sepsis, LBW, 
premature, and hyperbilirubinemia, the baby was stable 
and transportable, the patient’s parents were willing 
to participate and signed the informed consent. The 
study protocol was approved by Dr. Soetomo General 
Hospital Surabaya.
Several tools used for ear examination were 
headlamps, cotton wool, cotton, and otoscope. AABR: 
MB11 or BERA Phone was made by Maico, Germany 
in 2011. BERA tool: Interacoustics Assens DK-5610 
was made in Denmark, 2010. BERA was performed by 
a special officer from a limited liability company (PT) 
KASOEM Hearing on a schedule of inspection. The 
results of AABR and BERA were read by a specialist 
doctor of otorhinolaryngology-head and neck surgery 
and recorded in the data collection sheet; then the data 
were processed statistically.
The data were processed descriptively using 
a diagnostic test such as the calculation of sensitivity, 
specificity, positive predictive value, and negative 
predictive value; then it was followed by Wilcoxon 
signed-rank comparative test.
Results
Nineteen high-risk infants who fulfilled the 
inclusion criteria were enrolled in this study. The 
study was conducted in Neurotology Division of Dr. 
Soetomo General Hospital Surabaya from November 
2015 to September 2015. Each subject underwent two 
examinations of AABR and BERA on the right and left 
ear. The basic data of the subjects were age distribution, 
gender distribution, high-risk factors, AABR results, 
BERA results, and HL threshold from the BERA results.
Table 1: Age distribution
Age (month) Amount Percentage (%)
0–1 month 13 68.42
1–2 months 5 26.31
2–3 months 1 5.27
Total 19 100
Table 1 showed that the most age group of 
high-risk infants was 0–1 month’s as many as 13 infants 
(68.42%), whereas five infants in the age group of 1–2 
months (26.31%) and one baby in the age group of 2–3 
months (5.27%). The youngest was <1 month (9 days) 
and the oldest was <3 months (86 days) with mean age 
of 26.74 (21.07).
Table 2: Sex distribution
Sex Amount Percentage
Male 10 52.63
Female 9 47.37
Total 19 100
Table 2 showed 10 male infants (52.63%) and 
9 female infants (47.37%). The ratio of male to female 
was 1.1:1.
Table 3: High-risk factors distribution
Risk factors Amount Percentage
Asphyxia 13 68.42
Sepsis 0 0
Low birth weight 15 78.95
Premature 12 63.16
Hyperbilirubinemia 11 57.89
We found that the most risk factor was 
LBW of 15 infants (78.95%), asphyxia of 13 infants 
(68.42%), premature of 12 infants (63.16%). and 
hyperbilirubinemia of 11 infants (57.89%; Table 3).
Table 4: Automated auditory brainstem response results
Automated auditory brainstem response Amount Percentage
Pass (negative) 23 60.53
Refer (positive) 15 39.47
Total 38 100
Table 4 showed that the AABR results of pass 
(negative) were 23 infant ears (60.53%) and refer 
(positive) were 15 infant ears (39.47%). Distribution of 
subjects based on the BERA results could be seen in 
Table 5. BERA obtained normal (negative) results of 28 
infants (73.68%) and abnormal (positive) results of 10 
infants (26.32%).
Table 5: Brainstem evoked response audiometry results
Brainstem evoked response audiometry Amount Percentage
Normal (negative) 28 73.68
Abnormal (positive) 10 26.32
Total 38 100
The distribution of the subjects based on the 
threshold degree of the BERA results was shown in 
Table 6.
Table 6: Threshold degree of auditory based on brainstem 
evoked response audiometry results
Threshold degree Amount Percentage Description
0–25 dB 28 73.68 Normal
26–40 dB 10 26.32 Mild hearing loss
41–60 dB 0 Moderate hearing loss
61–90 dB 0 Severe hearing loss
>90 dB 0 Profound hearing loss
Total 38 100
The table obtained a normal threshold level 
of 28 infants (73.68%) at 0–25 dB or a V wave was 
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detected at 30 dB and a minor HL of 10 infants (26.32%) 
at 26–40 dB or V wave was detected at 40–50 dB.
Discussion
Table 1 showed the age of 19 high-risk babies. 
Auditory development in humans was closely related to 
the brain development. Neurons in the cortex undergo 
a maturation process in the first 3 years of life and a 
rapid brain development occurs in the first 12 months of 
life. The critical period for the development of hearing 
and speech systems begins in the first 6 months of 
life and it continues to grow until the age of 2 years. In 
Italy against 206 high-risk infants treated at NICU that 
used AABR AccuScreen PRO-GN Otometrics/Madsen 
Electronics/Copenhagen Denmark and BERA Galileo 
NT evoked response system (EBNeuro/Florence, 
Italy). One hundred and sixty-one infants aged 1 month 
(78.16%), 12 infants aged 2 months (5.83%), and 33 
babies aged 3 months (16.02%) [11].
Table 2 showed that 10 male infants (52.63%) 
and 9 female infants (47.37%) with the ratio of male to 
female were 1.1:1. There were differences of opinion 
between male and female. Several studies reported 
no gender differences in newborns. Male infants were 
more likely to experience brain maturation disorders, 
developmental disorders of brain white matter, and 
neural dysfunction; however, there was no mechanism 
that suggested which sex was susceptible to HL [12]. 
This study was in accordance to a study conducted 
by Cebulla and Shehata-Dieler in Germany of 6866 
newborns, they found 3604 male infants (52.5%) and 
3262 female infants (47.5%) [13].
High-risk infants with LBW or premature 
were at high risk of suffering from SNHL HL due to 
the immaturity of the anatomy and physiology of the 
auditory organs. LBW in a study conducted by Dewi 
and Agustin (2011) against 286 newborns showed 
that the highest risk factors were LBW of 146 infants 
(51.1%), premature of 39 infants (13.6%), asphyxia as 
many as 38 infants (13.3%), and hyperbilirubinemia 
of 25 infants (8.7%). The difference in this study 
was seen from the number of risk factors of affected 
infants.
Table 4 showed that the AABR with MB11 
BERAphone on 38 high-risk infants ears resulted in 23 
passes (60.53%) and 15 refers (39.47%). This study 
was in accordance with a study in Italy by Melagrana 
et al. with AABR MB11 BERAphone against 388 ears 
from 201 high-risk infants treated at NICU, they obtained 
pass results of 303 ears (78.09%) and refer as many 
as 85 ears (21.91%) [3]. The AABR device determined 
the presence or absence of a BERA wave using the 
scoring method without the need for visual inspection 
of operator skills. The data collected were processed by 
an algorithm to verify the statistic results (pass or refer). 
The AABR tool determined the presence of BERA 
waves by verifying the presence of the response at the 
low stimulus click level (e.g.,: 35 dBnHL). It examined 
whether the BERA signal was measured for the noise 
ratio beyond the defined criterion [12]. AABR waves 
could be recorded in premature infants at 34 weeks 
pregnancy [2].
Table 5 showed a normal BERR result 
of 28 infants (73.68%) and abnormal results of 10 
infants (26.32%). This study was in accordance 
with a research in Italy by Melagrana et al. using 
BERA Mercury Epic Audiological system software 
against 388 ears from 201 high-risk infants treated 
at NICU that obtained normal results of 313 ears 
(80.67%) and abnormal of 75 ears (19.33%) [3]. In 
Canada BERA Amplaid MK-15 was used to 120 high-
risk infant ears from 260 infants at NICU obtained 
normal results of 80 ears (66.67%) and abnormal of 
40 ears (3.33%) [14]. Nonpathological factors that 
might affect the outcome of BERA were age, gender, 
body temperature, general circumstances, and the 
influence of drugs. There was an elongation of BERA 
wave latency values in newborn infants aged up to 
28 days (neonates) compared to adults. Therefore, 
the BERA results in newborns have a characteristic 
interval between extended waves. BERA wave 
could be recorded in premature infants at 25 
weeks pregnancy with an average of 27–30 weeks 
pregnancy [12]. The premature infants in this study 
had an average pregnancy age of 28–35 weeks.
Table 6 showed the result of HL threshold 
from normal BERA examination result of 28 infant ear 
(73.68%) at 0–20 dB or V wave was detected at 30 
dB. There was mild HL of 10 infant ears (26.32%) at 
26–40 dB or V wave was detected at 40-50 dB. This 
study was in accordance with a research conducted 
by Chen et al., in Taiwan that obtained 36 normal ears 
(47.36%) and V wave was detected at 35 dB. Then, 
mild HL of 22 ears (28.94%) was obtained and V wave 
was detected at 45 dB. The moderate HL was obtained 
in 18 ears (23.68%) and V wave was detected at 60 dB 
of 76 infant ears aged 3–4 months [14].
The result of statistical calculation in this 
research using Wilcoxon signed-rank comparative test 
obtained p = 0.236. It could be concluded that there was 
no significant difference between AABR and BERA with 
sensitivity of 40% and specificity of 60.71%. It showed 
that AABR could be used as a BERA alternative in early 
detection of HL in high-risk infants. In Italy, 378 (97.4%) 
of 388 ears showed an agreement using two techniques 
of AABR and BERA, while there was no agreement 
using two techniques of AABR and BERA in 10 ears 
(2.6%) [3]. The result of interobserver agreement 
between AABR and BERA was very good (kappa = 
0.92 ± 0.02 S.E., p = 0.0001) with 100% sensitivity and 
96.8% specificity.
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Conclusion
Detection of HL in high-risk infants in NICU 
using AABR obtained 40% sensitivity and 60.71% 
specificity. There was no difference between the results 
of AABR and BERA for HL detection in high-risk infants 
in the NICU.
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